Shandong Lukang Pharmaceutical Co Ltd (600789) - Total Liabilities
Based on the latest financial reports, Shandong Lukang Pharmaceutical Co Ltd (600789) has total liabilities worth CN¥4.57 Billion CNY (≈ $668.77 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 600789 net asset momentum to track the company's year-over-year net asset growth rate.
Shandong Lukang Pharmaceutical Co Ltd - Total Liabilities Trend (1993–2025)
This chart illustrates how Shandong Lukang Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of Shandong Lukang Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
Shandong Lukang Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Shandong Lukang Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Puuilo Oyj
HE:PUUILO
|
Finland | €217.80 Million |
|
Jingjin Environmental Protection Co Ltd
SHG:603279
|
China | CN¥4.12 Billion |
|
Changzhou NRB Corp
SHE:002708
|
China | CN¥2.03 Billion |
|
Cohen & Steers Tax-Advantaged Preferred Securities and Income Fund
NYSE:PTA
|
USA | $610.54 Million |
|
SUPERLOOP LTD
F:9SL
|
Germany | €232.10 Million |
|
Beijing Haitian Ruisheng Science Technology Ltd
SHG:688787
|
China | CN¥116.34 Million |
|
SKAN Group AG
SW:SKAN
|
Switzerland | CHF347.81 Million |
|
Baota Industry Co Ltd
SHE:000595
|
China | CN¥9.27 Billion |
Liability Composition Analysis (1993–2025)
This chart breaks down Shandong Lukang Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 600789 market cap.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.53 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.88 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Shandong Lukang Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Shandong Lukang Pharmaceutical Co Ltd (1993–2025)
The table below shows the annual total liabilities of Shandong Lukang Pharmaceutical Co Ltd from 1993 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥4.78 Billion ≈ $699.08 Million |
-5.14% |
| 2024-12-31 | CN¥5.04 Billion ≈ $736.99 Million |
-0.49% |
| 2023-12-31 | CN¥5.06 Billion ≈ $740.60 Million |
-3.05% |
| 2022-12-31 | CN¥5.22 Billion ≈ $763.92 Million |
+18.91% |
| 2021-12-31 | CN¥4.39 Billion ≈ $642.45 Million |
+12.18% |
| 2020-12-31 | CN¥3.91 Billion ≈ $572.68 Million |
-0.10% |
| 2019-12-31 | CN¥3.92 Billion ≈ $573.27 Million |
+12.07% |
| 2018-12-31 | CN¥3.50 Billion ≈ $511.55 Million |
+12.66% |
| 2017-12-31 | CN¥3.10 Billion ≈ $454.08 Million |
+41.30% |
| 2016-12-31 | CN¥2.20 Billion ≈ $321.35 Million |
+3.93% |
| 2015-12-31 | CN¥2.11 Billion ≈ $309.20 Million |
-18.12% |
| 2014-12-31 | CN¥2.58 Billion ≈ $377.64 Million |
+5.77% |
| 2013-12-31 | CN¥2.44 Billion ≈ $357.05 Million |
+2.60% |
| 2012-12-31 | CN¥2.38 Billion ≈ $348.01 Million |
+33.03% |
| 2011-12-31 | CN¥1.79 Billion ≈ $261.60 Million |
+32.57% |
| 2010-12-31 | CN¥1.35 Billion ≈ $197.32 Million |
+44.94% |
| 2009-12-31 | CN¥930.38 Million ≈ $136.14 Million |
-7.01% |
| 2008-12-31 | CN¥1.00 Billion ≈ $146.41 Million |
-4.59% |
| 2007-12-31 | CN¥1.05 Billion ≈ $153.46 Million |
+4.18% |
| 2006-12-31 | CN¥1.01 Billion ≈ $147.31 Million |
-7.38% |
| 2005-12-31 | CN¥1.09 Billion ≈ $159.05 Million |
-9.62% |
| 2004-12-31 | CN¥1.20 Billion ≈ $175.99 Million |
+11.19% |
| 2003-12-31 | CN¥1.08 Billion ≈ $158.28 Million |
-1.78% |
| 2002-12-31 | CN¥1.10 Billion ≈ $161.14 Million |
-9.60% |
| 2001-12-31 | CN¥1.22 Billion ≈ $178.25 Million |
+6.90% |
| 2000-12-31 | CN¥1.14 Billion ≈ $166.74 Million |
+64.68% |
| 1999-12-31 | CN¥691.92 Million ≈ $101.25 Million |
+58.73% |
| 1998-12-31 | CN¥435.91 Million ≈ $63.79 Million |
-1.55% |
| 1997-12-31 | CN¥442.76 Million ≈ $64.79 Million |
+14.65% |
| 1996-12-31 | CN¥386.20 Million ≈ $56.51 Million |
+21.72% |
| 1995-12-31 | CN¥317.27 Million ≈ $46.43 Million |
+20.14% |
| 1994-12-31 | CN¥264.09 Million ≈ $38.64 Million |
+5.53% |
| 1993-12-31 | CN¥250.26 Million ≈ $36.62 Million |
-- |
About Shandong Lukang Pharmaceutical Co Ltd
Shandong Lukang Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in China. The company provides analgesics and antipyretics; gastrointestinal; endocrine; cardio-cerebrovascular; anti-infective; and other human formulation products. It offers human and veterinary active pharmaceutical ingredient; veterinary formulation; bio-pesticides; and amino acid. The company also exports its produ… Read more